Corporations

Seeking Protection for Whistleblowers That's Worth Its Salt

The case of Pierre Meneton is fueling demands for legal protections for whistleblowers in France. Meneton is a researcher for the National Institute of Health and the National Institute of Health and Medical Research. He is going to court on January 31, 2008, to face charges of defamation. Several industrial salt producers are suing Meneton for a comment he made during an interview in March 2006. "The lobbying of salt producers and agribusiness is very active.

No

CMD and Consumer Reports WebWatch Launch Full Frontal Scrutiny

"The American public deserves to know when someone is trying to persuade them." — U.S. Federal Communications Commissioner Jonathan Adelstein, Thursday, January 17, 2008

Front Groups Beware of Full Frontal Scrutiny

Front Groups - Appearances May Be DeceptiveToday, the Center for Media and Democracy and our partners at Consumer Reports WebWatch launched an exciting new project: Full Frontal Scrutiny. The site seeks to shine a light on front groups -- organizations that state a particular agenda, while hiding or obscuring their identity, membership or sponsorship, or all three. Google the term "front groups" and the number one return is CMD's extensive articles on its SourceWatch site.

When Flacks Attack, We Bite Back

The Center for Media and Democracy has never been shy about criticizing the public relations industry. That's what we do, and we're proud of it. You'd think that this would give PR people second thoughts before sending us their drivel. Unfortunately, they can't seem to help themselves -- even when that means that they end up tipping us off to their own efforts at sneaking product placements into TV shows such as American Idol.

Once Again, Drug Companies Caught Data Doping

The pharmaceutical companies Merck and Schering-Plough, which co-market the cholesterol drug Vytorin, "have gone into damage-control mode, taking out newspaper ads." The PR campaign follows the companies' reluctant publication of a study showing that neither of the drugs present in Vytorin "reduced the buildup of fatty plaque in arteries." The study "

No

Pages

Subscribe to Corporations